{
  "resourceType" : "ValueSet",
  "id" : "2.16.840.1.113762.1.4.1235.328",
  "meta" : {
    "versionId" : "6",
    "lastUpdated" : "2023-12-21T17:43:03.000-05:00",
    "profile" : [
      "http://hl7.org/fhir/StructureDefinition/shareablevalueset",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"
    ]
  },
  "extension" : [
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/valueset-author",
      "valueContactDetail" : {
        "name" : "B.well Connected Health Author"
      }
    },
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
      "valueDate" : "2024-07-02"
    },
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
      "valueDate" : "2023-06-16"
    }
  ],
  "url" : "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.328",
  "identifier" : [
    {
      "system" : "urn:ietf:rfc:3986",
      "value" : "urn:oid:2.16.840.1.113762.1.4.1235.328"
    }
  ],
  "version" : "20230616",
  "name" : "HighRiskHPVTest_HD_CPT",
  "title" : "High Risk HPV Test_HD_CPT",
  "status" : "active",
  "date" : "2023-06-16T01:00:56-04:00",
  "publisher" : "B.well Connected Health Steward",
  "description" : "b.well created value set by Sr. Clinical Business Analyst for High Risk HPV Test.",
  "jurisdiction" : [
    {
      "coding" : [
        {
          "system" : "urn:iso:std:iso:3166",
          "code" : "US"
        }
      ]
    }
  ],
  "purpose" : "(Clinical Focus: The intent of this value set is for the purpose of defining the clinical codes that constitute High Risk HPV Test for inclusion and utilization in patients/users connected heath.),(Data Element Scope: High Risk HPV Test for b.well.),(Inclusion Criteria: High Risk HPV Test Codes that constitute a Cancer Care Need for b.well.),(Exclusion Criteria: N/A)",
  "compose" : {
    "include" : [
      {
        "system" : "http://www.ama-assn.org/go/cpt",
        "concept" : [
          {
            "code" : "87620",
            "display" : "Infectious agent detection by nucleic acid (DNA or RNA); papillomavirus, human, direct probe technique"
          },
          {
            "code" : "87621",
            "display" : "Infectious agent detection by nucleic acid (DNA or RNA); papillomavirus, human, amplified probe technique"
          },
          {
            "code" : "87622",
            "display" : "Infectious agent detection by nucleic acid (DNA or RNA); papillomavirus, human, quantification"
          },
          {
            "code" : "87624",
            "display" : "Infectious agent detection by nucleic acid (DNA or RNA); Human Papillomavirus (HPV), high-risk types (eg, 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68)"
          },
          {
            "code" : "87625",
            "display" : "Infectious agent detection by nucleic acid (DNA or RNA); Human Papillomavirus (HPV), types 16 and 18 only, includes type 45, if performed"
          }
        ]
      }
    ]
  },
  "expansion" : {
    "identifier" : "urn:uuid:0d947544-64b2-488d-8a88-83eacb32c7da",
    "timestamp" : "2025-05-23T20:23:08-04:00",
    "total" : 2,
    "contains" : [
      {
        "system" : "http://www.ama-assn.org/go/cpt",
        "version" : "2025",
        "code" : "87624",
        "display" : "Infectious agent detection by nucleic acid (DNA or RNA); Human Papillomavirus (HPV), high-risk types (eg, 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68), pooled result"
      },
      {
        "system" : "http://www.ama-assn.org/go/cpt",
        "version" : "2025",
        "code" : "87625",
        "display" : "Infectious agent detection by nucleic acid (DNA or RNA); Human Papillomavirus (HPV), types 16 and 18 only, includes type 45, if performed"
      }
    ]
  }
}
